Search PNTG
Pennant Group, Inc.
Nasdaq · CIK 1766400
Last close39.24
Daily change+0.45 (1.16%)
10 Years gain+160.04%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
PNTG · STANDARD
SIC 8000 · Services-Health Services · Fiscal year end 1231
Fundamental
60.5Momentum
48.3Acceleration
43.6Confidence
79.0Annual Revenue9
Quarterly Revenue24
Annual CFO9
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth24.2 / 25
Quality18.7 / 25
Capital Efficiency10.5 / 20
Balance Sheet3.0 / 15
Shareholder Economics1.0 / 10
Forward Indicators3.0 / 5
Signals
No positive signals calculated.
Warnings
ROIC declining · MEDIUMROIC declined by 2.6624 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM44.08%OK
Revenue CAGR 3Y26.05%OK
Gross Marginn/aMISSING
Operating Margin5.45%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC8.67%OK
Incremental Operating Margin 3Y8.94%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y2.14%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $947.71M | n/a | $51.89M | $48.29M | $36.26M | n/a | 5.47% | 3.83% | 9.44% | 35.32M |
| 2025 FY Dec 31, 2024 | $695.24M | n/a | $38.12M | $39.30M | $30.31M | n/a | 5.48% | 4.36% | 12.05% | 32M |
| 2025 FY Dec 31, 2023 | $544.89M | n/a | $25.17M | $33.09M | $24.99M | n/a | 4.62% | 4.59% | 9.17% | 30.19M |
| 2024 FY Dec 31, 2022 | $473.24M | n/a | $12.74M | $9.04M | -$5.13M | n/a | 2.69% | -1.08% | 5.98% | 30.16M |
| 2023 FY Dec 31, 2021 | $439.69M | n/a | $4.70M | -$18.22M | -$24.53M | n/a | 1.07% | -5.58% | 2.74% | 30.64M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.03B | sum latest 4 fiscal quarters Revenue | OK | 0001766400-26-000065, 0001766400-25-000139 |
| Revenue Growth TTM | 44.08% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001766400-26-000065, 0001766400-25-000139 |
| Revenue CAGR 3Y | 26.05% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001766400-26-000014 |
| Revenue CAGR 5Y | 19.37% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001766400-26-000014 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | 35.45% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001766400-26-000065, 0001766400-25-000139 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Margin | 5.45% | Operating Income / Revenue | OK | 0001766400-26-000065, 0001766400-25-000139 |
| ROIC | 8.67% | NOPAT / Average Invested Capital | OK | 0001766400-26-000065, 0001766400-25-000139 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001766400-26-000065 |
| Current Ratio | 1.2x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.08x | (Cash + Short-term Investments) / Total Debt | OK | 0001766400-26-000065 |
| Revenue per Diluted Share | $28.70 | Revenue / Diluted Shares | OK | 0001766400-26-000065, 0001766400-25-000139 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |